Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010301567 | R857 B56 2012 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
There have been important developments in materials and therapies for the treatment of spinal conditions. Biomaterials for spinal surgery summarises this research and how it is being applied for the benefit of patients.
After an introduction to the subject, part one reviews fundamental issues such as spinal conditions and their pathologies, spinal loads, modelling and osteobiologic agents in spinal surgery. Part two discusses the use of bone substitutes and artificial intervertebral discs whilst part three covers topics such as the use of injectable biomaterials like calcium phosphate for vertebroplasty and kyphoplasty as well as scoliosis implants. The final part of the book summarises developments in regenerative therapies such as the use of stem cells for intervertebral disc regeneration.
With its distinguished editors and international team of contributors, Biomaterials for spinal surgery is a standard reference for both those developing new biomaterials and therapies for spinal surgery and those using them in clinical practice.
Author Notes
Luigi Ambrosio is Director of the Institute for Composite and Biomedical Materials, National Research Council of Italy. Elizabeth Tanner is Professor of Biomedical Materials at the University of Glasgow, UK. Both are noted for their research in born" biomaterial and therapies.
Table of Contents
Contributor contact details | p. xiii |
1 Introduction to biomaterials for spinal surgery | p. 1 |
1.1 Introduction | p. 1 |
1.2 Total disc replacement | p. 3 |
1.3 Nucleus pulposus replacement | p. 5 |
1.4 Materials for spinal applications | p. 7 |
1.5 Conclusions | p. 28 |
1.6 References | p. 29 |
Part 1 Fundamentals of biomaterials for spinal surgery | p. 39 |
2 An overview of the challenges of bringing a medical device for the spine to the market | p. 41 |
2.1 Introduction | p. 41 I |
2.2 Selection and sourcing of materials in medical device developments | p. 43 |
2.3 Biocompatibility testing | p. 50 |
2.4 Medical device regulation | p. 59 |
2.5 Conclusions | p. 73 |
2.6 Acknowledgement | p. 74 |
2.7 References | p. 74 |
3 Introduction to spinal pathologies and clinical problems of the spine | p. 78 |
3.1 Introduction | p. 78 |
3.2 Degenerative spine disease | p. 80 |
3.3 Spinal trauma | p. 88 |
3.4 Spinal deformity | p. 97 |
3.5 Malignancy | p. 105 |
3.6 Infection | p. 108 |
3.7 Conclusions | p. 109 |
3.8 References | p. 110 |
4 Forces on the spine | p. 114 |
4.1 Introduction | p. 114 |
4.2 In vivo measured components of spinal loads | p. 115 |
4.3 In vitro measured spinal load components | p. 126 |
4.4 Analytical models for spinal load estimation | p. 129 |
4.5 Recommendations for the simulations of loads for in vitro and numerical studies | p. 133 |
4.6 Conclusions | p. 137 |
4.7 References | p. 137 |
5 Finite element modelling of the spine | p. 144 |
5.1 Introduction | p. 144 |
5.2 Functional spine biomechanics and strength of numerical explorations | p. 144 |
5.3 Geometrical approximations in spine finite element modelling | p. 156 |
5.4 Numerical approximations: accuracy and computational cost | p. 166 |
5.5 Constitutive models for the spine tissues | p. 179 |
5.6 Simulating the mechanical loads on the spine | p. 201 |
5.7 Model verifications and interpretations: the validation concept and quantitative validation | p. 207 |
5.8 Future trends and conclusions: the virtual physiological spine | p. 218 |
5.9 References | p. 219 |
6 Osteobiologic agents in spine surgery | p. 233 |
6.1 Introduction | p. 233 |
6.2 Bone formation and healing | p. 234 |
6.3 Osteobiologics for spine fusion | p. 239 |
6.4 Bone growth factors | p. 245 |
6.5 Cellular biologies | p. 251 |
6.6 Conclusions | p. 256 |
6.7 References | p. 257 |
Part II Spinal fusion and intervertebral discs | p. 263 |
7 Spine fusion: cages, plates and bone substitutes | p. 265 |
7.1 Introduction | p. 265 |
7.2 Spine fusion: historical concerns and surgical skills | p. 266 |
7.3 Bone substitutes in spine fusion | p. 276 |
7.4 Bone growth factors | p. 284 |
7.5 Autologous bone marrow | p. 286 |
7.6 Future trends | p. 287 |
7.7 References | p. 288 |
8 Artificial intervertebral discs | p. 295 |
8.1 Introduction | p. 295 |
8.2 Structure and function of the intervertebral disc | p. 296 |
8.3 The artificial intervertebral disc: design and materials | p. 298 |
8.4 Fibre-reinforced composite materials: basic principles | p. 301 |
8.5 Composite biomimetic artificial intervertebral discs | p. 303 |
8.6 Future trends and conclusions | p. 309 |
8.7 References | p. 310 |
9 Biological response to artificial discs | p. 313 |
9.1 Introduction | p. 313 |
9.2 The healing response to intervertebral disc implants | p. 316 |
9.3 Infection as a cause of failure of implants | p. 322 |
9.4 Loosening and the reaction to the products of wear and corrosion | p. 324 |
9.5 Carcinogenicity and genotoxicity of metal implants | p. 346 |
9.6 Conclusions | p. 347 |
9.7 References | p. 348 |
Part III Vertebroplasty and scoliosis surgery | p. 363 |
10 The use of polymethyl methacrylate (PMMA) in neurosurgery | p. 365 |
10.1 Introduction: a history of polymethyl methacrylate(PMMA) | p. 365 |
10.2 Characteristics of polymethyl methacrylate (PMMA) | p. 366 |
10.3 Preparation of polymethyl methacrylate (PMMA) for use in clinical practice | p. 370 |
10.4 Clinical use of polymethyl methacrylate (PMMA) in neurosurgery | p. 376 |
10.5 Developments in polymethyl methacrylate (PMMA) | p. 380 |
10.6 Conclusions | p. 382 |
10.7 Sources of further information | p. 383 |
10.8 References | p. 383 |
11 Optimising the properties of injectable materials for vertebroplasty and kyphoplasty | p. 385 |
11.1 Introduction | p. 385 |
11.2 Polymethyl methacrylate (PMMA) based bone cements | p. 390 |
11.3 Calcium phosphate and calcium sulfate based bone cements | p. 396 |
11.4 Conclusions | p. 399 |
11.5 References | p. 399 |
12 Injectable calcium phosphates for vertebral augmentation | p. 404 |
12.1 Introduction | p. 404 |
12.2 Polymethyl methacrylate (PMMA) | p. 405 |
12.3 Calcium phosphate cements | p. 406 |
12.4 Conclusions | p. 410 |
12.5 References | p. 411 |
13 Composite injectable materials for vertebroplasty | p. 414 |
13.1 Introduction: a background on the use of composites in vertebroplasty | p. 414 |
13.2 Properties of composites for vertebroplasty | p. 416 |
13.3 Further development in composite injectable materials | p. 425 |
13.4 Conclusions | p. 428 |
13.5 References | p. 428 |
14 Scoliosis implants' surgical requirements | p. 432 |
14.1 Introduction | p. 432 |
14.2 Definition of scoliosis | p. 435 |
14.3 Management of scoliosis | p. 441 |
14.4 eneral principles for spinal fusion | p. 448 |
14.5 Outcomes in scoliosis surgery | p. 451 |
14.6 Future development of biomechanical implants | p. 455 |
14.7 Conclusions | p. 458 |
14.8 Sources of further information | p. 458 |
14.9 References | p. 458 |
15 Shape memory, superelastic and low Young's modulus alloys | p. 462 |
15.1 Introduction | p. 462 |
15.2 Fundamental characteristics of shape memory and superelastic alloys | p. 463 |
15.3 Low Young's modulus alloys | p. 479 |
15.4 Metals required for spinal surgery | p. 480 |
15.5 Conclusions | p. 486 |
15.6 Acknowledgements | p. 486 |
15.7 References | p. 486 |
Part IV Regenerative medicine in the spine | p. 491 |
16 Cell-based tissue engineering approaches for disc regeneration | p. 493 |
16.1 Introduction | p. 493 |
16.2 Rationale behind the use of cells | p. 494 |
16.3 Choice of cell type (not including mesenchymalstem cells) | p. 498 |
16.4 Current issues to be addressed | p. 500 |
16.5 Future trends and conclusions | p. 503 |
16.6 Sources of further information | p. 505 |
16.7 References | p. 506 |
17 Angiogenesis control in spine regeneration | p. 510 |
17.1 Introduction | p. 510 |
17.2 The role and the mechanisms of angiogenesis | p. 511 |
17.3 Physiological and pathological vascularisation of different intervertebral disc (IVD) histological compartments | p. 514 |
17.4 Strategies to promote angiogenesis in tissue regeneration | p. 517 |
17.5 Angiogenesis inhibition in intervertebral disc (IVD) | p. 522 regenera |
17.6 Future trends | p. 528 |
17.7 Sources of further information | p. 529 |
17.8 Acknowledgements | p. 530 |
17.9 References | p. 530 |
18 Stem cells for disc regeneration536M. J. Loughran and J. A. Hunt, University of Liverpool, UK | |
18.1 Introduction | p. 536 |
18.2 Tissue engineering solutions for intervertebral disc (IVD) disease | p. 539 |
18.3 Mesenchymal stem cells (MSC) .and regeneration of the intervertebral disc (IVD) | p. 541 |
18.4 Regeneration of the annulus | p. 551 |
18.5 use of scaffolds with mesenchymal stem cells (MSC) for intervertebral disc (IVD) regeneration | p. 552 |
18.6 Future trends | p. 554 |
18.7 Conclusions | p. 556 |
18.8 References | p. 557 |
19 Nucleus regeneration | p. 563 |
19.1 Introduction | p. 563 |
19.2 The intervertebral disc: anatomy, structure and function | p. 565 |
19.3 Mechanics-biology interrelation | p. 566 |
19.4 Annulus, nucleus and entire intervertebraldisc: the tissue engineering approach | p. 567 |
19.5 Conclusions | p. 576 |
19.6 References | p. 576 |
20 In vivo models of regenerative medicine in the spine | p. 582 |
20.1 Introduction | p. 582 |
20.2 Selecting an animal model | p. 584 |
20.3 Intervertebral spinal fusion | p. 589 |
20.4 Degenerative disc disease | p. 592 |
20.5 Future trends and conclusions | p. 597 |
20.6 Acknowledgements | p. 598 |
20.7 References | p. 598 |
Index | p. 608 |